Current Developments in Combining External-Beam Radiotherapy and (177)Lu-Labeled PSMA Ligands for Prostate Cancer Treatment. Teunissen FR, Oprea-Lager DE, Peters SMB, Smeenk RJ, et al. J Nucl Med 2025 Oct 3:jnumed.125.270465. doi: 10.2967/jnumed.125.270465.

Read + Share

Amedeo Smart

Independent Medical Education

Teunissen FR, Oprea-Lager DE, Peters SMB, Smeenk RJ, et al. Current Developments in Combining External-Beam Radiotherapy and (177)Lu-Labeled PSMA Ligands for Prostate Cancer Treatment. J Nucl Med 2025 Oct 3:jnumed.125.270465. doi: 10.2967/jnumed.125.270465.
PMID: 41044003